As demand for new medicines rises, compound library facilities remain essential for enabling reliable, collaborative drug discovery. While scientists work to develop novel therapeutics for rare ...

Pharmaceutical companies amass huge libraries of chemical compounds they can test to see if one just might be capable of being developed into a new drug. But what if, even with millions of compounds, ...

Even before companies spend exorbitant amounts on clinical trials (most of which fail), they already have spent significant time and money identifying the best drug candidates for those trials.

Compound library storage underpins modern drug discovery, chemical biology, and screening-driven research. It refers to the controlled systems, conditions, and practices used to preserve collections ...

Recent successes of immunomodulatory approaches for the treatment of serious diseases such as cancer have generated a significant growth in efforts aimed at the discovery of novel therapeutics in this ...

Sanofi and AstraZeneca have struck a deal in which they will exchange 210,000 chemicals from their respective compound libraries. The goal is to enhance the diversity of each company’s collection, ...

Tokyo, Japan – March 19, 2014 – Astellas Pharma Inc. ("Astellas"; Tokyo: 4503; President and CEO: Yoshihiko Hatanaka) and Daiichi Sankyo Company, Limited ("Daiichi Sankyo," President and CEO: Joji ...

Combinatorial chemistry has been widely adopted by the pharmaceutical industry in the past decade. However, owing to perceived “failures” with this technology, the pharmaceutical industry has been ...

Peptide Tracker, the free peptide protocol tracking app for iOS and Android, today announced a series of updates (v2.15.0 through v2.17.0) that give users more precise dosing tools, a fully custom ...

Over the past two decades, large genetic studies have linked tens of thousands of DNA variants to thousands of human traits and diseases. Yet, correcting the effects of those variants to treat disease ...